European Archives - Page 26 of 1218 - European Medical Journal

EMJ Hematology 13 [Supplement 3] 2025

In this insightful new interview, key opinion leader Talha Munir reviews the current landscape of chronic lymphocytic leukaemia (CLL), and…

Sotatercept Shows Sustained Benefit in Pulmonary Hypertension Study

A long-term study finds sotatercept continues to improve outcomes in patients with pulmonary arterial hypertension, with manageable safety risks.

Diabetes May Increase Bone Density Without Decreasing Fracture Risk

Understand how diabetes may raise bone density over time, but fracture risk remains.

Optimal Care of Unfit Patients with FTL3+ AML

Acute myeloid leukaemia (AML) is a rapidly progressing myeloid neoplasm caused by the clonal expansion of primitive haematopoietic stem…

Comparative Study Questions Cardiovascular Safety of Glipizide

Discover how new research found that glipizide carries higher cardiovascular risk than DPP4 inhibitors in Type 2 diabetes treatment.

Modifiable Risk Factors Behind Majority of Liver Cancers

At least 60% of liver cancer diagnoses are linked to modifiable risk factors and could be prevented through global interventions

Pharmacist-Led Approach Improves Allergic Rhinitis Outcomes

The study found that patients receiving the AR-PRISE intervention experienced significant improvements in symptom control, particularly over the longer term.

I-O for Resectable NSCLC

In this symposium, Frank Griesinger, Cecilia Pompili, and Jesme Fox discussed the latest evidence for neoadjuvant and…

New Heights in Paediatric Cholestasis

If you couldn’t attend the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) 2025 Annual Meeting in…

Review of HLTH Europe 2025

EUROPE’s number one healthcare innovation event, HLTH Europe, was held this year in Amsterdam, the Netherlands, from the 16th–19th June…